"I encourage some patients to stay at the lower dose level for a longer period of time to see if they can tolerate it better and still get some benefit from the medication
To date, the U.S
Dongiovanni P, Valenti L, Ludovica Fracanzani A, et al
Exercise performance: VO2 max proxies (pace at a given heart rate), strength output, and recovery speed between sessions are all relevant markers
Discontinuation rates due to adverse events in TRIUMPH-3 were 9.8% (9 mg) and 13.5% (12 mg) with retatrutide, compared with 4.8% for placebo
Commonly reported side effects may include nausea, vomiting, diarrhea, constipation, decreased appetite, stomach discomfort, or fatigue, particularly during dose adjustments